Literature DB >> 23564308

Middle cerebral O₂ delivery during the modified Oxford maneuver increases with sodium nitroprusside and decreases during phenylephrine.

Julian M Stewart1, Marvin S Medow, Andrew DelPozzi, Zachary R Messer, Courtney Terilli, Christopher E Schwartz.   

Abstract

The modified Oxford maneuver is the reference standard for assessing arterial baroreflex function. The maneuver comprises a systemic bolus injection of 100 μg sodium nitroprusside (SNP) followed by 150 μg phenylephrine (PE). On the one hand, this results in an increase in oxyhemoglobin and total hemoglobin followed by a decrease within the cerebral sample volume illuminated by near-infrared spectroscopy (NIRS). On the other hand, it produces a decrease in cerebral blood flow velocity (CBFv) within the middle cerebral artery (MCA) during SNP and an increase in CBFv during PE as measured by transcranial Doppler ultrasound. To resolve this apparent discrepancy, we hypothesized that SNP dilates, whereas PE constricts, the MCA. We combined transcranial Doppler ultrasound of the right MCA with NIRS illuminating the right frontal cortex in 12 supine healthy subjects 18-24 yr old. Assuming constant O₂ consumption and venous saturation, as estimated by partial venous occlusion plethysmography, we used conservation of mass (continuity) equations to estimate the changes in arterial inflow (ΔQa) and venous outflow (ΔQv) of the NIRS-illuminated area. Oxyhemoglobin and total hemoglobin, respectively, increased by 13.6 ± 1.6 and 15.2 ± 1.4 μmol/kg brain tissue with SNP despite hypotension and decreased by 6 ± 1 and 7 ± 1 μmol/kg with PE despite hypertension. SNP increased ΔQa by 0.36 ± .03 μmol·kg(-1)·s(-1) (21.6 μmol·kg(-1)·min(-1)), whereas CBFv decreased from 71 ± 2 to 62 ± 2 cm/s. PE decreased ΔQa by 0.27 ± .2 μmol·kg(-1)·s(-1) (16.2 μmol·kg(-1)·min(-1)), whereas CBFv increased to 75 ± 3 cm/s. These results are consistent with dilation of the MCA by SNP and constriction by PE.

Entities:  

Keywords:  cerebral blood flow; middle cerebral artery; near-infrared spectroscopy; nitric oxide; vasodilation

Mesh:

Substances:

Year:  2013        PMID: 23564308      PMCID: PMC3680723          DOI: 10.1152/ajpheart.00114.2013

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  36 in total

1.  Numerical simulation and experimental validation of blood flow in arteries with structured-tree outflow conditions.

Authors:  M S Olufsen; C S Peskin; W Y Kim; E M Pedersen; A Nadim; J Larsen
Journal:  Ann Biomed Eng       Date:  2000 Nov-Dec       Impact factor: 3.934

2.  Factors affecting the accuracy of near-infrared spectroscopy concentration calculations for focal changes in oxygenation parameters.

Authors:  Gary Strangman; Maria Angela Franceschini; David A Boas
Journal:  Neuroimage       Date:  2003-04       Impact factor: 6.556

3.  Effects of the nitric oxide synthase inhibitor L-NMMA on cerebrovascular and cardiovascular responses to hypoxia and hypercapnia in humans.

Authors:  Kojiro Ide; Matthew Worthley; Todd Anderson; Marc J Poulin
Journal:  J Physiol       Date:  2007-08-02       Impact factor: 5.182

4.  Measurement of cerebral venous saturation in adults using near infrared spectroscopy.

Authors:  C E Elwell; S J Matcher; L Tyszczuk; J H Meek; D T Delpy
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

5.  The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study.

Authors:  R P White; C Hindley; P M Bloomfield; V J Cunningham; P Vallance; D J Brooks; H S Markus
Journal:  J Cereb Blood Flow Metab       Date:  1999-06       Impact factor: 6.200

6.  Nitric oxide mediates the neurogenic vasodilation of bovine cerebral arteries.

Authors:  C González; C Estrada
Journal:  J Cereb Blood Flow Metab       Date:  1991-05       Impact factor: 6.200

7.  Inhibition of nitric oxide synthase does not alter dynamic cerebral autoregulation in humans.

Authors:  Rong Zhang; Thad E Wilson; Sarah Witkowski; Jian Cui; Graig G Crandall; Benjamin D Levine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03       Impact factor: 4.733

8.  Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with 15O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan.

Authors:  Hiroshi Ito; Iwao Kanno; Chietsugu Kato; Toshiaki Sasaki; Kenji Ishii; Yasuomi Ouchi; Akihiko Iida; Hidehiko Okazawa; Kohei Hayashida; Naohiro Tsuyuguchi; Kazunari Ishii; Yasuo Kuwabara; Michio Senda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-17       Impact factor: 9.236

9.  Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery.

Authors:  F Y Chen; T J Lee
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

10.  The effects of sodium nitroprusside on cerebral blood flow and cerebral venous blood gases. I. Observations in awake man during and following moderate blood pressure reduction.

Authors:  L Henriksen; O B Paulson; M Lauritzen
Journal:  Eur J Clin Invest       Date:  1982-10       Impact factor: 4.686

View more
  13 in total

Review 1.  Integrative regulation of human brain blood flow.

Authors:  Christopher K Willie; Yu-Chieh Tzeng; Joseph A Fisher; Philip N Ainslie
Journal:  J Physiol       Date:  2014-01-06       Impact factor: 5.182

2.  Phenylephrine alteration of cerebral blood flow during orthostasis: effect on n-back performance in chronic fatigue syndrome.

Authors:  Marvin S Medow; Shilpa Sood; Zachary Messer; Seli Dzogbeta; Courtney Terilli; Julian M Stewart
Journal:  J Appl Physiol (1985)       Date:  2014-10-02

3.  Reduced cerebral blood flow with orthostasis precedes hypocapnic hyperpnea, sympathetic activation, and postural tachycardia syndrome.

Authors:  Andrew T Del Pozzi; Christopher E Schwartz; Deepali Tewari; Marvin S Medow; Julian M Stewart
Journal:  Hypertension       Date:  2014-04-07       Impact factor: 10.190

4.  Indexes of cerebral autoregulation do not reflect impairment in syncope: insights from head-up tilt test of vasovagal and autonomic failure subjects.

Authors:  Pedro Castro; João Freitas; Rosa Santos; Ronney Panerai; Elsa Azevedo
Journal:  Eur J Appl Physiol       Date:  2017-07-05       Impact factor: 3.078

5.  Influence of cerebrovascular resistance on the dynamic relationship between blood pressure and cerebral blood flow in humans.

Authors:  J D Smirl; Y C Tzeng; B J Monteleone; P N Ainslie
Journal:  J Appl Physiol (1985)       Date:  2014-04-17

6.  Blunted cerebral blood flow velocity in response to a nitric oxide donor in postural tachycardia syndrome.

Authors:  Andrew T Del Pozzi; Akash Pandey; Marvin S Medow; Zachary R Messer; Julian M Stewart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-30       Impact factor: 4.733

7.  Oscillatory lower body negative pressure impairs task related functional hyperemia in healthy volunteers.

Authors:  Julian M Stewart; Keshawadhana Balakrishnan; Paul Visintainer; Andrew T Del Pozzi; Zachary R Messer; Courtney Terilli; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-22       Impact factor: 4.733

8.  Oscillatory lower body negative pressure impairs working memory task-related functional hyperemia in healthy volunteers.

Authors:  Sana Merchant; Marvin S Medow; Paul Visintainer; Courtney Terilli; Julian M Stewart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 5.125

9.  Effects of midodrine and L-NAME on systemic and cerebral hemodynamics during cognitive activation in spinal cord injury and intact controls.

Authors:  Jill M Wecht; Joseph P Weir; Miroslav Radulovic; William A Bauman
Journal:  Physiol Rep       Date:  2016-02

10.  Lack of linear correlation between dynamic and steady-state cerebral autoregulation.

Authors:  Daan L K de Jong; Takashi Tarumi; Jie Liu; Rong Zhang; Jurgen A H R Claassen
Journal:  J Physiol       Date:  2017-07-14       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.